INTERLEUKIN 5 BINDENDES PROTEIN-DOSIERUNGSREGELN

Patent europeic · EP4267184 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP4267184
Numer da la dumonda
EP21844228
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
20-12-2021
Publitgà
01-11-2023
Concedì
26-11-2025
Stritgà
23-07-2026
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/395 (2006.01)
C07K 16/24 (2006.01)
Prioritad
US 202063128922 P 22.12.2020
US 202163192854 P 25.05.2021
US 202163220182 P 09.07.2021
US 202163285513 P 03.12.2021
Dumonda PCT
PCT/EP2021/086689 20.12.2021
Publicaziun PCT
WO2022/136209 30.06.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 07-10-2026

    Midada

    Published in Swissreg on 07.10.2026

  2. 23-07-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2026

  3. 26-11-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.11.2025

Partidas

Possessur

GlaxoSmithKline Intellectual Property Development Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB

Inventur

AUSTIN, Daren J

Brentford Middlesex TW8 9GS, GB

BIRD, Nicholas P

Stevenage Hertfordshire SG1 2NY, GB

MONCK, Myrna A

Collegeville, Pennsylvania 19426, US

POULIQUEN, Isabelle J

Brentford Middlesex TW8 9GS, GB

SHUMAN, Melissa A

Collegeville, Pennsylvania 19426, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.